Elixir sulfanilamide

Results: 15



#Item
1 Better protecting the patients Be aware of the system

Better protecting the patients Be aware of the system

Add to Reading List

Source URL: www.pharmacovigilance2012.nl

Language: English - Date: 2011-11-29 08:04:15
2Consumer Health Information www.fda.gov/consumer FDA Historians Share Lessons From Agency’s Past

Consumer Health Information www.fda.gov/consumer FDA Historians Share Lessons From Agency’s Past

Add to Reading List

Source URL: www.fda.gov.

Language: English
3CENTER FOR STRATEGIC AND INTERNATIONAL STUDIES (CSIS) THE SAFETY OF FOOD AND DRUG IMPORTS WELCOME AND MODERATOR: J. STEPHEN MORRISON, SENIOR VICE PRESIDENT AND DIRECTOR,

CENTER FOR STRATEGIC AND INTERNATIONAL STUDIES (CSIS) THE SAFETY OF FOOD AND DRUG IMPORTS WELCOME AND MODERATOR: J. STEPHEN MORRISON, SENIOR VICE PRESIDENT AND DIRECTOR,

Add to Reading List

Source URL: csis.org

Language: English - Date: 2010-02-04 15:55:40
4History of the U.S. Food and Drug Administration  Title:

History of the U.S. Food and Drug Administration Title:

Add to Reading List

Source URL: www.fda.gov

Language: English
5FDA Oral History, Sherman

FDA Oral History, Sherman

Add to Reading List

Source URL: www.fda.gov

Language: English
6Food and Drug Administration / Pharmaceuticals policy / Pharmacology / Elixir sulfanilamide / Diethylene glycol / Sulfonamide / Federal Food /  Drug /  and Cosmetic Act / Pharmaceutical drug / Elixir / Medicine / Adulteration / Health

FDA Consumer magazine - June 1981 Issue   Taste of Raspberries, Taste of Death The 1937 Elixir Sulfanilamide Incident By the 1930s it was widely recognized that the Food and Drugs Act of 1906 was obsolete, but bitter di

Add to Reading List

Source URL: www.fda.gov

Language: English
7Microsoft Word - 7654fnl.doc

Microsoft Word - 7654fnl.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
81st Meeting of the Neonatal Subcommittee of the Pediatric Advisory Committee

1st Meeting of the Neonatal Subcommittee of the Pediatric Advisory Committee

Add to Reading List

Source URL: www.fda.gov

Language: English
9Marketed, Unapproved Drugs Lori Cantin, R.Ph., Pharm.D. CDR, USPHS Division of New Drugs and Labeling Compliance Office of Compliance

Marketed, Unapproved Drugs Lori Cantin, R.Ph., Pharm.D. CDR, USPHS Division of New Drugs and Labeling Compliance Office of Compliance

Add to Reading List

Source URL: www.fda.gov

Language: English
10Overview of the FDA and the Office of Orphan Products Development (OOPD)

Overview of the FDA and the Office of Orphan Products Development (OOPD)

Add to Reading List

Source URL: www.fda.gov

Language: English